« previous next »
Pages: [1]   Go Down

Author Topic: Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials  (Read 95 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 699
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials
« on: August 09, 2024, 07:46:19 AM »
Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials

For decades, researchers have worked to develop therapies that can prime the immune system to recognize and attack proteins on the surface of tumor cells.
Source: Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials
Logged
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)

Individualized neoantigen cancer therapy demonstrates safety and efficacy in early trials
« on: August 09, 2024, 07:46:19 AM »
Pages: [1]   Go Up
« previous next »
 


Powered by EzPortal